2025-07-29 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided, formatted for a concise English report.

## Natera Inc. (NTRA) Analysis Report

**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing for reproductive health, oncology, and organ health.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return:** NTRA: 116.81%, VOO: 99.93%
*   **Spread:** Current: 17.2%, Relative Spread: 8.4% (Indicates NTRA is currently outperforming VOO, but the relative spread suggests it is in the lower end of its historical outperformance range)

**Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta | Cap(B) |
|------------|---------|---------|---------|------|--------|
| 2015-2017  | -6.0%   | 62.4%   | -31.0%  | 0.0 | 1.2    |
| 2016-2018  | 29.0%   | 80.1%   | 11.0%   | 0.0 | 1.9    |
| 2017-2019  | 159.0%  | 80.1%   | 130.0%  | 1.2 | 4.6    |
| 2018-2020  | 530.0%  | 80.1%   | 510.0%  | 0.3 | 13.6   |
| 2019-2021  | 355.0%  | 62.9%   | 307.0%  | 0.2 | 12.8   |
| 2020-2022  | -119.0% | 62.9%   | -121.0% | 0.2 | 5.5    |
| 2021-2023  | -482.0% | 69.9%   | -500.0% | 1.1 | 8.6    |
| 2022-2024  | -75.0%  | 70.6%   | -100.0% | 1.2 | 21.6   |
| 2023-2025  | 66.0%   | 75.3%   | 14.0%   | 0.8 | 18.8   |

*   **Alpha/Beta Analysis:** The Alpha values show significant outperformance in some periods (e.g., 2018-2020, 2019-2021), but also considerable underperformance in others (e.g., 2021-2023, 2020-2022, 2022-2024). Beta values fluctuate, indicating varying degrees of correlation with the market. The high MDD(Maximum Drawdown) values suggest high volatility.

### 2. Recent Price Action

*   **Current Price:** $138.0
*   **Last Market Close:** Price: $138.0, Previous Close: $138.9, Change: -0.65%
*   **Moving Averages:** 5-day: 139.14, 20-day: 151.56, 60-day: 157.55

**Analysis:** The stock price has decreased slightly compared to the previous close. The 5-day moving average is below the 20-day and 60-day moving averages, suggesting a short-term downtrend.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3286 (Low Risk)
*   **RSI:** 24.52 (Oversold)
*   **PPO:** -1.09
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33)
*   **Recent Relative Divergence Change (20-day):** -0.5 (Negative - Short-term decline)
*   **Expected Return:** 198.3% (Long-term, vs. S&P 500)

**Analysis:** The RSI indicates the stock may be oversold, potentially signaling a buying opportunity. The negative PPO suggests a downward trend. The recent decrease of the realtive divergence could be related to the slight drop in price. The Hybrid Signal suggests a cautious approach. The expected return is very high, and could be a good incentive to investment but also a signal of risk.

### 4. Recent News & Events

*   **Recent News:** Recent news mentions major business developments, regulatory changes, market events, analyst discussions, volatility influenced by earnings reports, and expert advice to monitor news.

**Analysis:** These news snippets suggest that NTRA is subject to market fluctuations and external factors, emphasizing the importance of staying up-to-date on company-specific and broader market news.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue |
|------------|-------|---------|
| 2025-05-09 | -0.5  | $0.50B  |
| 2024-11-12 | -0.26 | $0.44B  |
| 2024-08-09 | -0.3  | $0.41B  |
| 2024-05-10 | -0.56 | $0.37B  |
| 2025-05-09 | -0.56 | $0.37B  |

**Analysis:** The company has consistently reported negative EPS, but revenue has generally been increasing over the past year. This may be related to the increasing Equity and Profit Margin.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.50B  | 63.12%        |
| 2024-12-31 | $0.48B  | 62.94%        |
| 2024-09-30 | $0.44B  | 61.79%        |
| 2024-06-30 | $0.41B  | 58.83%        |
| 2024-03-31 | $0.37B  | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE    |
|------------|---------|--------|
| 2025-03-31 | $1.24B  | -5.40% |
| 2024-12-31 | $1.20B  | -4.50% |
| 2024-09-30 | $0.88B  | -3.60% |
| 2024-06-30 | $0.84B  | -4.48% |
| 2024-03-31 | $0.79B  | -8.51% |

**Analysis:** Revenue and profit margins have been increasing, while ROE remains negative. This suggests that the company is still not profitable despite revenue growth.

### 7. Overall Summary

Natera Inc. (NTRA) shows potential for long-term growth, driven by increasing revenue and high expected returns. However, the company also faces significant challenges, including negative earnings, high volatility, and ongoing negative ROE. The technical indicators suggest a possible oversold condition, but recent price action indicates a short-term downtrend. Recent news suggests that NTRA is responsive to external factors. Investors should closely monitor company announcements and financial performance. The high expected return could be seen as an incentive, but the volatility should be taken into consideration.
